-
Something wrong with this record ?
Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin
W. Jablonka, M. Kotsyfakis, DM. Mizurini, RQ. Monteiro, J. Lukszo, SK. Drake, JM. Ribeiro, JF. Andersen,
Language English Country United States
Document type Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-10-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Platelet Aggregation drug effects MeSH
- Anticoagulants chemistry isolation & purification pharmacology MeSH
- Blood Coagulation drug effects MeSH
- Ticks chemistry MeSH
- Humans MeSH
- Molecular Sequence Data MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Peptides chemistry isolation & purification pharmacology MeSH
- Amino Acid Sequence MeSH
- Sequence Alignment MeSH
- Thrombin antagonists & inhibitors metabolism MeSH
- Thrombosis drug therapy MeSH
- Blood Coagulation Tests MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Intramural MeSH
A group of peptides from the salivary gland of the tick Hyalomma marginatum rufipes, a vector of Crimean Congo hemorrhagic fever show weak similarity to the madanins, a group of thrombin-inhibitory peptides from a second tick species, Haemaphysalis longicornis. We have evaluated the anti-serine protease activity of one of these H. marginatum peptides that has been given the name hyalomin-1. Hyalomin-1 was found to be a selective inhibitor of thrombin, blocking coagulation of plasma and inhibiting S2238 hydrolysis in a competitive manner with an inhibition constant (Ki) of 12 nM at an ionic strength of 150 mM. It also blocks the thrombin-mediated activation of coagulation factor XI, thrombin-mediated platelet aggregation, and the activation of coagulation factor V by thrombin. Hyalomin-1 is cleaved at a canonical thrombin cleavage site but the cleaved products do not inhibit coagulation. However, the C-terminal cleavage product showed non-competitive inhibition of S2238 hydrolysis. A peptide combining the N-terminal parts of the molecule with the cleavage region did not interact strongly with thrombin, but a 24-residue fragment containing the cleavage region and the C-terminal fragment inhibited the enzyme in a competitive manner and also inhibited coagulation of plasma. These results suggest that the peptide acts by binding to the active site as well as exosite I or the autolysis loop of thrombin. Injection of 2.5 mg/kg of hyalomin-1 increased arterial occlusion time in a mouse model of thrombosis, suggesting this peptide could be a candidate for clinical use as an antithrombotic.
Critical Care Medicine Department Clinical Center
Institute of Parasitology Academy of Sciences of the Czech Republic České Budejovice Czech Republic
National Institutes of Health Bethesda Maryland United States of America
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020443
- 003
- CZ-PrNML
- 005
- 20160722120044.0
- 007
- ta
- 008
- 160722s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0133991 $2 doi
- 024 7_
- $a 10.1371/journal.pone.0133991 $2 doi
- 035 __
- $a (PubMed)26244557
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jablonka, Willy $u Laboratory of Malaria and Vector Research, NIAID, National Institutes of Health, Rockville, Maryland, United States of America.
- 245 10
- $a Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin / $c W. Jablonka, M. Kotsyfakis, DM. Mizurini, RQ. Monteiro, J. Lukszo, SK. Drake, JM. Ribeiro, JF. Andersen,
- 520 9_
- $a A group of peptides from the salivary gland of the tick Hyalomma marginatum rufipes, a vector of Crimean Congo hemorrhagic fever show weak similarity to the madanins, a group of thrombin-inhibitory peptides from a second tick species, Haemaphysalis longicornis. We have evaluated the anti-serine protease activity of one of these H. marginatum peptides that has been given the name hyalomin-1. Hyalomin-1 was found to be a selective inhibitor of thrombin, blocking coagulation of plasma and inhibiting S2238 hydrolysis in a competitive manner with an inhibition constant (Ki) of 12 nM at an ionic strength of 150 mM. It also blocks the thrombin-mediated activation of coagulation factor XI, thrombin-mediated platelet aggregation, and the activation of coagulation factor V by thrombin. Hyalomin-1 is cleaved at a canonical thrombin cleavage site but the cleaved products do not inhibit coagulation. However, the C-terminal cleavage product showed non-competitive inhibition of S2238 hydrolysis. A peptide combining the N-terminal parts of the molecule with the cleavage region did not interact strongly with thrombin, but a 24-residue fragment containing the cleavage region and the C-terminal fragment inhibited the enzyme in a competitive manner and also inhibited coagulation of plasma. These results suggest that the peptide acts by binding to the active site as well as exosite I or the autolysis loop of thrombin. Injection of 2.5 mg/kg of hyalomin-1 increased arterial occlusion time in a mouse model of thrombosis, suggesting this peptide could be a candidate for clinical use as an antithrombotic.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antikoagulancia $x chemie $x izolace a purifikace $x farmakologie $7 D000925
- 650 _2
- $a hemokoagulace $x účinky léků $7 D001777
- 650 _2
- $a vyšetření krevní srážlivosti $7 D001780
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a peptidy $x chemie $x izolace a purifikace $x farmakologie $7 D010455
- 650 _2
- $a agregace trombocytů $x účinky léků $7 D010974
- 650 _2
- $a sekvenční seřazení $7 D016415
- 650 _2
- $a trombin $x antagonisté a inhibitory $x metabolismus $7 D013917
- 650 _2
- $a trombóza $x farmakoterapie $7 D013927
- 650 _2
- $a klíšťata $x chemie $7 D013987
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Intramural $7 D052060
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kotsyfakis, Michalis $u Institute of Parasitology, Academy of Sciences of the Czech Republic, České Budejovice, Czech Republic.
- 700 1_
- $a Mizurini, Daniella M $u Instituto de Bioquimica Médica Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- 700 1_
- $a Monteiro, Robson Q $u Instituto de Bioquimica Médica Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- 700 1_
- $a Lukszo, Jan $u Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
- 700 1_
- $a Drake, Steven K $u Critical Care Medicine Department, Clinical Center; National Institutes of Health, Bethesda, Maryland, United States of America.
- 700 1_
- $a Ribeiro, José M C $u Laboratory of Malaria and Vector Research, NIAID, National Institutes of Health, Rockville, Maryland, United States of America.
- 700 1_
- $a Andersen, John F $u Laboratory of Malaria and Vector Research, NIAID, National Institutes of Health, Rockville, Maryland, United States of America. $7 gn_A_00006077
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 8 (2015), s. e0133991
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26244557 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160722120258 $b ABA008
- 999 __
- $a ok $b bmc $g 1155113 $s 944971
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 10 $c 8 $d e0133991 $e 20150805 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20160722